These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17616674)

  • 21. p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor.
    Gotoh T; Cai D; Tian X; Feig LA; Lerner A
    J Biol Chem; 2000 Sep; 275(39):30118-23. PubMed ID: 10896938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
    Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
    Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
    Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
    Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Cas-BCAR3 co-regulatory circuit controls lamellipodia dynamics.
    Steenkiste EM; Berndt JD; Pilling C; Simpkins C; Cooper JA
    Elife; 2021 Jun; 10():. PubMed ID: 34169835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCAR3 regulates EGF-induced DNA synthesis in normal human breast MCF-12A cells.
    Oh MJ; van Agthoven T; Choi JE; Jeong YJ; Chung YH; Kim CM; Jhun BH
    Biochem Biophys Res Commun; 2008 Oct; 375(3):430-4. PubMed ID: 18722344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.
    Yde CW; Emdal KB; Guerra B; Lykkesfeldt AE
    Breast Cancer Res Treat; 2012 Aug; 135(1):67-78. PubMed ID: 22527100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.
    van Agthoven T; Sieuwerts AM; Meijer D; Meijer-van Gelder ME; van Agthoven TL; Sarwari R; Sleijfer S; Foekens JA; Dorssers LC
    Endocr Relat Cancer; 2010 Mar; 17(1):215-30. PubMed ID: 19966015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
    Brinkman A; de Jong D; Tuinman S; Azaouagh N; van Agthoven T; Dorssers LC
    Breast Cancer Res Treat; 2010 Apr; 120(2):401-8. PubMed ID: 19412734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
    Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
    BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue.
    van der Flier S; van der Kwast TH; Claassen CJ; Timmermans M; Brinkman A; Henzen-Logmans SC; Foekens JA; Dorssers LC
    Int J Biol Markers; 2001; 16(3):172-8. PubMed ID: 11605729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.
    Clarke R; Liu MC; Bouker KB; Gu Z; Lee RY; Zhu Y; Skaar TC; Gomez B; O'Brien K; Wang Y; Hilakivi-Clarke LA
    Oncogene; 2003 Oct; 22(47):7316-39. PubMed ID: 14576841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.
    Cutrupi S; Reineri S; Panetto A; Grosso E; Caizzi L; Ricci L; Friard O; Agati S; Scatolini M; Chiorino G; Lykkesfeldt AE; De Bortoli M
    Oncogene; 2012 Oct; 31(40):4353-61. PubMed ID: 22249258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling.
    Vervoort VS; Roselli S; Oshima RG; Pasquale EB
    Gene; 2007 Apr; 391(1-2):161-70. PubMed ID: 17270363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells.
    Deng H; Yin L; Zhang XT; Liu LJ; Wang ML; Wang ZY
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():417-26. PubMed ID: 25158023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antiestrogens on EGF-mediated movement of human breast cancer cells.
    Tong GM; Rajah TT; Zang XP; Bahr SJ; Pento JT
    Pharmacology; 2007; 79(2):93-6. PubMed ID: 17164579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells.
    van Agthoven T; van Agthoven TL; Dekker A; van der Spek PJ; Vreede L; Dorssers LC
    EMBO J; 1998 May; 17(10):2799-808. PubMed ID: 9582273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids.
    Konstantinovsky S; Davidson B; Reich R
    Clin Exp Metastasis; 2012 Aug; 29(6):527-40. PubMed ID: 22476538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.